ORGANIC
LETTERS
2008
Vol. 10, No. 16
3429-3431
Total Synthesis of GEX1A
Timothy J. Murray† and Craig J. Forsyth*,‡
Department of Chemistry, The Ohio State UniVersity, 100 West 18th AVenue,
Columbus, Ohio 43210-1185, and GlaxoSmithKline, 553 Old CorVallis Road,
Hamilton, Montana 59840
Received April 18, 2008
ABSTRACT
An efficient and readily modifiable synthesis of GEX1A/herboxidiene/TAN-1609 (1) was developed. This modular synthesis featured a Suzuki coupling
to install the conjugated diene and a Ru-catalyzed lactonization and Roush crotylation to construct the functionalized tetrahydropyran moiety. Myers’
alkylation, cross-metathesis, and Keck crotylation were employed for assembly of the biologically essential side-chain domain.
GEX1A (1, also known as herboxidiene and TAN-1609) is an
interesting microbial natural product that was first described in
the primary literature in 1992 by Isaac and co-workers.1
Thereafter, the absolute configuration of 1 was reported by a
group at Novartis in 1997.2 GEX1A induces an array of diverse
xenobiotic responses that include herbicidal activity,1 activation
of the LDL receptor,3 an increase of G1 and G2 cell phase
population,4–6 and antitumor activity in numerous cell lines.4–6
Recent publications characterized naturally occurring GEX1A
analogues that replicate several of these biological re-
sponses.5,6 However, the cellular mechanisms and modes of
action of 1 and its cogeners remain to be elucidated. The
provision of GEX1A and structural varaints and derived
cellular probes should enable studies to accomplish this.
Two initial synthetic entries to the GEX1A architecture were
reported by Kocienski and Banwell, respectively. Kocienski7
described the first total synthesis of 1 in 1999, whereas Banwell8
elaborated upon this benchmark in reporting a formal total
synthesis in 2000. Edmunds9 subsequently published the
syntheses of simpler, non-natural analogues of 1, whereas Panek
published a signature silane-based total synthesis of 1 in 2007.10
The combination of enticing structural features, ammenable
to convergent assembly, and opportunities to enable further
chemical biology studies compelled us to develop a flexible
synthetic entry to this unique class of natural products.11
Our synthetic plan for 1 focused on the construction of the
diene via a Suzuki coupling of vinyl iodide 2 and vinyl boronate
3 (Scheme 1).12 Disconnection of the C1-C2 acetate and the
C8 vinyl iodide of 2 revealed lactone 4 (Scheme 2). A Ru-
catalyzed carbonylation of homoallylic alcohol 5 was designed
† GlaxoSmithKline.
‡ The Ohio State University.
(1) Isaac, B. G.; Ayer, S. W.; Elliott, R. C.; Stonard, R. J. J. Org. Chem.
1992, 57, 7220.
(2) Edmunds, A. J. F.; Trueb, W.; Oppolzer, W.; Cowley, P. Tetrahedron
1997, 53, 2785.
(7) Blakemore, P. R.; Kocienski, P. J.; Morley, A.; Muir, K. J. Chem.
Soc., Perkin Trans. 1 1999, 995.
(3) Koguchi, Y.; Nishio, M.; Kotera, J.; Omori, K.; Ohnuki, T.;
Komatsubara, S. J. Antibiot. 1997, 50, 970.
(4) Horiguchi, T.; Shirasaki, M.; Tanida, S. Takeda Kenkyushoho 1996,
(8) Banwell, M.; McLeod, M.; Premaj, R.; Simpson, G. Pure Appl.
Chem. 2000, 72, 1631.
55, 149
.
(9) Edmunds, A. J. F.; Arnold, G.; Hagmnaa, L.; Schaffner, R.;
Furlenmeier, H. Bioorg. Med. Chem. Lett. 2000, 10, 1365.
(10) Zhang, Y.; Panek, J. S. Org. Lett. 2007, 9, 3141.
(11) The work described here has been previously documented: Murray,
T. J. Ph.D. Thesis, 2006, University of Minnesota.
(12) Suzuki, A. J. Organomet. Chem. 1999, 576, 147.
(5) Sakai, Y.; Yoshida, T.; Ochiai, K.; Uosaki, Y.; Saitoh, Y.; Tanaka,
F.; Akiyama, T.; Akinaga, S.; Mizukami, T. J. Antibiot. 2002, 55, 855
.
(6) Sakai, Y.; Tsujita, T.; Akiyama, T.; Yoshida, T.; Mizukami, T.;
Akinaga, S.; Horinouchi, S.; Yoshida, M.; Yoshida, T. J. Antibiot. 2002,
55, 863
.
10.1021/ol800902g CCC: $40.75
Published on Web 07/19/2008
2008 American Chemical Society